Vaginal Dinoprostone system (Propess®)
ProcedureLabour will be induced using the vaginal Dinoprostone system (Propess®) as a first strategy
NCT Number: NCT04452747
Labour induction is an obstetrical procedure, which artificially starts the process of cervix dilation, in order to induce labour. Several methods of labour induction exist : mechanical ones (using dilatation balloons) or pharmacological ones (using prostaglandins or oxytocin). This trial aims to compare, in case of non-favourable cervix, the strategy of labour induction using the Propess® method first (Dino-first) versus the strategy beginning with the use of a dilatation balloon (Ballon-first), with respect of the usual practice and the current guidelines.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Montpellier University Hospital, Montpellier, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Labour will be induced using the vaginal Dinoprostone system (Propess®) as a first strategy
Labour will be induced using a cervix dilatation balloon as a first strategy
Time frame: On the day of the delivery
Rate of vaginal deliveries (both spontaneous or instrumentally assisted)
Time frame: On the day of the delivery
Number of spontaneous vaginal deliveries
Time frame: On the day of the delivery
Number of instrumentally assisted vaginal deliveries, including the reason for the assistance
Time frame: On the day of the delivery
Number of C-section including the reason for the C-section. The reasons for the C-section can be : a failure of dilatation at the first stage of the labour (between 0 and 10 cm), an absence of foetal descent at the second stage of labour, a foetal reason or a maternal reason)
Time frame: On the day of the delivery
Time elapsed between the beginning of the induction and the beginning of the labour
Time frame: at 12 hours, 24 hours and 48 hours
Cumulated number of spontaneous vaginal deliveries at 12 hours, 24 hours and 48 hours
Time frame: On the day of the delivery
Rate of labour induction failure is measure by the number of C-sections carried out due to a latency phase (0-6cm), which lasted more than 24 hours, together with the administration of oxytocin for at least 12 to 18 hours after the membranes artifically broke.
Time frame: On the day of the delivery
Number of secondary or tertiary use of Propess, Foley catheter of intra-veinous oxytocin
Time frame: On the day of the delivery
Number of peridural anaesthesia during labour
Time frame: On the day of the delivery
Uterine hyperstimulation is described as a number of contractions of 6 or more within 10 minutes, repeating at least twice). Foetal impact is defined as a slowing of the foetal heart rate.
Time frame: On the day of the delivery
Uterine hyperstimulation is described as a number of contractions of 6 or more within 10 minutes, repeating at least twice). Foetal impact is defined as a slowing of the foetal heart rate.
Time frame: On the day of the delivery
Uterine hypertonia is describes as a frequency of contractions every 2 minutes or less together with a slowing of the foetal heart rate.
Time frame: On the day of the delivery
Rate of post-partum haemorrhagia above 500 mL, above 1000 mL, transfusion level and number of packed red blood cells transfused
Time frame: On the day of the delivery
Number of patients with a uterine rupture
Time frame: On the day of the delivery
Number of patients with intra-uterine infections (body temperature above 38°C measured twice within 30 minutes, associated to 2 criteria within the followings: foetal tachycardia above 160 beats per minute, pain of the uterus or painful uterus contractions ou spontaneous labour induction, or purulent amniotic fluid.
Time frame: One week after day of the delivery
Number of patients with post-partum infections (body temperature above 38°C with antibiotic treatment, urinary tract infections, bacteriological endometritis)
Time frame: On the day of the delivery
Number of fetuses with neonatal asphyxia
Time frame: Up to four days after the delivery
Number of newborn babies hospitalized in Neonatal intensive care unit
Time frame: Up to four days after the delivery
Number of proven bacteriological infections in newborn babies
Time frame: On the day of the delivery
Number of women who experienced metrorrhagias while putting in place the dilatation balloon or the vaginal pad (dinoprostone)
Time frame: On the day of the delivery
Measurement of Pain will be made using an Visual Analog Scale (VAS). The pain level will be linked to the inflation of the dilatation balloon and requiring the partial deflation of the balloon
Time frame: On the day of the delivery
Measurement will be made using a Visual Analog Scale (VAS) and will be recorded at different times of the dilatation balloon or the dinoprostone vaginal pad set up
Time frame: Up to two weeks after the delivery
Patient experience will be assessed using the W-DEQ (Wijma Delivery Expectancy/Experience Questionnaire)
Time frame: through study completion, an average of 3 years
The costs of the treatment and duration of the hospitalization will be measured
University Hospital, Montpellier
Other
Artificial Induction of Labour in Full-term Singleton Pregnancy : Comparative Randomized Clinical Trial of Two Strategies (DINO-FIRST Versus BALLON-FIRST)
Acronym: BESTWAY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06787521
Pregnancy Related
Portland, Oregon, United States
View Trial DetailsNCT06640842
Alzheimer Disease, Brain Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT04253626
Anemia, Anemia, Hypochromic
Stanford, California, United States
View Trial DetailsNCT03242174
Lifestyle, Pregnancy Related
Baton Rouge, Louisiana, United States
View Trial Details